MO

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended March 31, 2000, for Philip Morris Companies Inc. (Note: The input metadata referenced "Altria Group," but the filing text explicitly identifies the registrant as Philip Morris Companies Inc.). The company operates through reportable segments including domestic and international tobacco, North American and international food, beer, and financial services. The financial statements are unaudited.

Key Financial Metrics

Dividends: $0.48 per share declared for the quarter. Stock Repurchases: $921 million spent on repurchasing 45.2 million shares.

Material Changes vs. Prior Period

• Revenue Growth: Operating revenues increased 2.8% ($543 million) year-over-year, driven primarily by a 22.1% increase in domestic tobacco revenues due to higher volume and pricing (including a federal excise tax increase).
• Profitability: Net earnings rose 12.4% to $2.0 billion. Operating income increased 10.0% to $3.478 billion.
• Unusual Items Impact: The 1999 comparison period included $287 million in pre-tax charges related to the Louisville factory closure ($130 million) and Kraft separation programs ($157 million). Excluding these charges and Century Date Change (CDC) revenue shifts, adjusted operating income increased 3.8%.
• Currency Impact: Strong U.S. dollar movements decreased operating revenues by $673 million and operating companies income by $93 million compared to 1999.
• Segment Performance:
  • Domestic Tobacco: Revenues up $986 million; Operating companies income up $198 million.
  • International Tobacco: Revenues down 4.7% due to currency and CDC shifts; Operating companies income flat.
  • North American Food: Revenues up 1.3%; Operating companies income up 26.6% (heavily influenced by the absence of 1999 separation charges).

Outlook, Risks, and Contingencies

Legal Proceedings: The company faces substantial litigation risks, most notably the Engle class action trial in Florida. A jury recently awarded $12.7 million in compensatory damages to three named plaintiffs; punitive damages for the entire class are pending. The company also faces a federal lawsuit by the U.S. government seeking over $20 billion annually in health care cost recovery.

Settlement Obligations: Under the Master Settlement Agreement (MSA), the domestic tobacco industry is obligated to make substantial annual payments, starting at $9.2 billion in 2000. Additionally, a trust fund for tobacco growers requires industry payments totaling $5.15 billion over 12 years.

Regulatory Environment: Risks include potential increases in federal and state excise taxes, FDA regulation challenges (though the Supreme Court recently ruled against FDA jurisdiction), and ingredient disclosure laws. The company notes that economic instability in Central and Eastern Europe continues to adversely affect international tobacco volumes.

Accounting Changes: The adoption of SFAS No. 133 (Derivatives) has been postponed to January 1, 2001; the impact on financial position remains undetermined.

Investor Verification Checklist

• Engle Trial Outcome: Monitor the upcoming punitive damages phase in the Florida Engle class action, which could result in a class-wide award.
• MSA Payment Impact: Verify the cash flow impact of the $9.2 billion annual Master Settlement Agreement payments and the associated price increases passed to consumers.
• Currency Exposure: Assess the continued impact of a strong U.S. dollar against the Euro and other currencies on international tobacco and food segments.
• Regulatory Changes: Track legislative developments regarding federal excise tax increases and state-level fire-safety standards for cigarettes.
• Stock Repurchase Program: Confirm the remaining authority under the $8 billion share repurchase program (expires November 2001).